Concepedia
Statistics
Publications
8
Citations
689
H-Index
Active since
2006
Affiliations
Moffitt Cancer Center(Current)
Boehringer Ingelheim (United States)
University of South Florida
Howard Hughes Medical Institute
Joseph Wahle is an author at Moffitt Cancer Center.
Publications per year
2006–2023
RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
Koen Venken, Peggy Jacques, Céline Mortier et al. · Nature Communications · 2018 · 306 citations · Full text
MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment
Julie M. Elliott, Joseph Wahle, Wayne M. Yokoyama · The Journal of Experimental Medicine · 2010 · 210 citations · Full text
Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell
Joseph Wahle, Kim H.T. Paraiso, Robert D. Kendig et al. · The Journal of Immunology · 2007 · 50 citations
An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients
Helena Bassolas-Molina, Ernest Raymond, Mark E. Labadia et al. · Frontiers in Immunology · 2018 · 47 citations · Full text
Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets
Joseph Wahle, Kim H.T. Paraiso, Amy L. Costello et al. · The Journal of Immunology · 2006 · 35 citations
1–5 of 8